Back to search

University of Crete (UOC)

Φλεγμονή και αναλγησία: ρόλος των νευροπεπτιδίων του στρές

Abstract

dc:description

Inflammatory response is part of the innate immune response of the organism to factors that stimulate the immune system and cause stress, such as pathogenic microorganisms, chemicals, radiation or even trauma. Some of the symptoms of inflammation are: oedema, redness, local increase of the temperature and pain. One of the main factors that regulate the reaction of the organism to stressors is Corticotropin Releasing Hormone (CRH), a neuropeptide that was first found in ovine hypothalamus. CRΗ produced in the CNS (Central Nervous System) exerts indirect anti-inflammatory effects through the final product of the activation of the HPA axis, glucocorticoids from adrenal cortex. CRH is produced not only in regions of the CNS, but in several peripheral tissues and cells and tissues of the immune system as well. Locally expressed CRH shows pro-inflammatory effect. Central and local CRH exerts its anti-inflammatory and pro-inflammatory effects respectively, through the activation of two so far known receptors, CRF1 and CRF2 receptors. It's known that inflammatory diseases, including rheumatoid arthritis, are characterised by the sensation of chronic pain. Initially, the process of pain by the organism was attributed solely to mechanisms of the nervous system, but today there are many studies that show the production of molecules that induce analgesia (opioids) in peripheral inflamed tissues. Peripheral CRH induces the production of opioids from cells of the immune system, which in turn bind to their receptors on the terminals of sensory neurons and reduce the feeling of pain. Those studies involve mainly pharmacological experiments or experiments in which the gene of CRH was inactivated locally. The aim of the present study was to investigate the role of endogenous CRH in inflammatory pain. For this purpose, we used the CRH knockout (Crh-/-) mouse model in our experiments as well as their wild type littermates (Crh+/+). Crh-/- mice are characterized, among other characteristics, by very low basal levels of glucocorticoids in plasma. Mice of both genotypes were injected with CFA (Complete Freund's Adjuvant) in their left hind paw while their right hind paw remained untreated and served as control. To evaluate differences in pain thresholds we used the Plantar Test (Hargreaves Apparatus). Measurements were taken 3, 6 and 24 hours after CFA injection. Our results showed that Crh-/- mice had lower pain thresholds compared to Crh+/+ mice regarding to their inflamed paws. Paw oedema was estimated by a Plethysmometer. Crh-/- mice developed a more intense local paw oedema 3 hours after CFA injection which remained high up to 24 hours. In order to study further the CFA induced inflammation at cellular and molecular level, local inflamed paws were isolated 6 hours after CFA injection, a time point at which most differences in pain reaction and paw oedema were found. Histological evaluation showed a more intense inflammatory response in Crh-/- mice, as a higher leukocyte infiltration was observed in their inflamed paws compared to Crh+/+ mice. Furthermore, the levels of proinflammatory cytokines, IL-6, TNF-α and IL-1β were increased in inflamed paws of Crh-/- mice. These mice had also higher plasma IL-6 concentration than wild type mice. To clarify further the role of CRH and their receptors (CRF1 and CRF2) in the inflammatory pain model we used, we studied the expression of mRNA levels of these molecules in inflamed paws of both genotypes. CRH mRNA expression was not detected in inflamed paws of Crh-/- mice, as it was expected, but no expression was found in wild type mice either. Both receptors were expressed in inflamed paws of both genotypes, although Crh-/- mice showed a lower expression of CRF2 mRNA. No differences were found in CRF1 mRNA levels between the two genotypes. Concerning the induction of opioid synthesis in inflamed tissues, POMC mRNA levels were lower in paws from Crh-/- mice compared to Crh+/+ mice, 6 and 24 hours post CFA injection. To investigate the effect of glucocrticoid insufficiency of Crh-/- mice in the model of inflammatory pain we used, pain thresholds and paw oedema were estimated following glucocorticoid replacement of Crh-/- mice. Basal levels of glucocorticoids in Crh-/- mice were achieved by administration of corticosterone in their drinking water for four days before the induction of inflammation. No difference in pain thresholds and paw oedema were found between Crh-/- mice with corticosterone replacement and wild type mice. The results of the present study show for the first time the role of endogenous CRH in inflammatory pain. CRH deficiency resulted in decreased pain thresholds and at the same time in a more intense inflammatory reaction. Both outcomes confirm the anti-inflammatory role of CRH in CFA induced inflammation, partially mediated by the low levels of glucocorticoids in Crh-/- mice. Indeed, glucocorticoid administration improved significantly the status of Crh-/- mice regarding the inflammatory markers and the production of molecules that cause analgesia. Further studies are in progress which will try to explain the molecular mechanisms of CRH and glucocorticoids and the molecular pathways involved in inflammatory pain.

Degree

thesis:*
Grantor dc:publisher
University of Crete (UOC)
Year dc:date
2024

Author and committee

dc:creator, dc:contributor.*
Authors dc:creator
  • Karagianni, Efthymia
  • Καραγιάννη, Ευθυμία

Subjects

dc:subject × 16

Rights

Language dc:language
gre

Identifiers

dc:identifier.*
Identifier
10.12681/eadd/56866

Chain of custody

source
Harvested from
Greek National Archive of PhD Theses
Base URL
phdtheses.ekt.gr/eadd_oai/request
Last updated
2026-11-18
Source record
OAI-PMH GetRecord
citation

Karagianni, Efthymia; Καραγιάννη, Ευθυμία. Φλεγμονή και αναλγησία: ρόλος των νευροπεπτιδίων του στρές. University of Crete (UOC), 2024. http://hdl.handle.net/10442/hedi/56866